Caspase-GLO(r) 3/7 assay
Ended Awarded Last action
- Contract number
- 75N95024F00001
- Awardee
-
Promega Corporation UEI MWM4N9L4S5X4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $22,487
Award facts
- Contract value 100% obligated
- $22,486.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Madison, WI 53711, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a Firm Fixed Price Blanket Purchase Agreement (BPA) Call to Promega Corporation for the CASPASE-GLO(R) 3/7 ASSAY. The potential value of the contract is $22,486.80 and the period of performance runs through March 8, 2024. Promega Corporation is a global life sciences company that provides DNA analysis equipment, reagents, assays, and related laboratory supplies to support biomedical research and testing programs across federal agencies. This award is part of a larger $10 million BPA Promega holds with the NIH Office of Logistics and Acquisition Operations for biological materials, chemicals, medical equipment, and maintenance services.
Quick answers
Who was awarded contract 75N95024F00001?
75N95024F00001 was awarded to Promega Corporation by National Institute on Drug Abuse (National Institutes of Health) on February 23, 2024.
How much is contract 75N95024F00001 worth?
The government has obligated $22,487 on 75N95024F00001.
Which agency awarded contract 75N95024F00001?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95024F00001, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95024F00001 an order under another contract?
Yes. 75N95024F00001 is a BPA call under 75N98024A00046, a blanket purchase agreement.
Was contract 75N95024F00001 competed?
The extent of competition for 75N95024F00001 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award